Cargando…
Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019
OBJECTIVE: To explore the clinical value of immune-inflammatory markers to assess the severity of coronavirus disease 2019 (COVID-19). METHODS: 127 consecutive hospitalized patients with confirmed COVID-19 were enrolled in this study, and classified into non-severe and severe groups. Demographics, s...
Autores principales: | Zhu, Zhe, Cai, Ting, Fan, Lingyan, Lou, Kehong, Hua, Xin, Huang, Zuoan, Gao, Guosheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195003/ https://www.ncbi.nlm.nih.gov/pubmed/32334118 http://dx.doi.org/10.1016/j.ijid.2020.04.041 |
Ejemplares similares
-
The potential role of serum angiotensin-converting enzyme in coronavirus disease 2019
por: Zhu, Zhe, et al.
Publicado: (2020) -
Low serum level of apolipoprotein A1 may predict the severity of COVID‐19: A retrospective study
por: Zhu, Zhe, et al.
Publicado: (2021) -
Absent immune response to SARS-CoV-2 in a 3-month recurrence of coronavirus disease 2019 (COVID-19) case
por: Gao, Guosheng, et al.
Publicado: (2020) -
Anti-inflammatory and immune therapy in severe coronavirus disease 2019 (COVID-19) patients: An update
por: Zhang, Wen, et al.
Publicado: (2022) -
Value of hematological parameters for predicting patients with severe
coronavirus disease 2019: a real-world cohort from Morocco
por: Azghar, Ali, et al.
Publicado: (2022)